Survey: More than a third of Americans either unlikely or unsure to get a COVID-19 vaccine

NewsGuard 100/100 Score

News reports indicate COVID-19 vaccines are not getting out soon enough nor inadequate supplies to most regions, but there may be a larger underlying problem than shortages. A University of California, Davis, study found that more than a third of people nationwide are either unlikely or at least hesitant to get a COVID-19 vaccine when it becomes available to them.

The results are from public polling of more than 800 English-speaking adults nationwide in a study published online earlier this month in the journal Vaccine.

Our research indicates that vaccine uptake will be suboptimal ... with 14.8 percent of respondents being unlikely to get vaccinated and another 23 percent unsure."

Jeanette B. Ruiz, Study Lead Author and Assistant Professor of Teaching Communication, University of California - Davis

"Even though vaccination remains one of the most effective public health initiatives, some still doubt the efficacy and safety of vaccines. Unfortunately, the seemingly rushed process of the COVID-19 vaccine may have further fueled these doubts."

The co-author is Robert Bell, emeritus professor of communication, UC Davis.

Respondents cited vaccine safety and effectiveness assessments as the primary basis for hesitancy, authors said.

In the study, compensated participants were recruited from the United States through an Internet survey panel of 2.5 million residents developed by a commercial survey firm. Recruitment was based on quota sampling to produce a U.S. census-matched sample representative of the nation and was representative of the U.S. population in terms of region of residence, sex, and age, but also diverse with regard to all demographic variables assessed.

Researchers measured the respondents' intention to vaccinate; demographic and health status profile of individuals least likely to vaccinate; general vaccine knowledge and vaccine conspiracy beliefs; and the role of media and partisan politics played in their resistance to vaccination.

A political party, health risk factors, media contribute to attitudes

The authors indicated demographic characteristics, vaccine knowledge, perceived vulnerability to COVID-19, risk factors for COVID-19, and politics likely contribute to vaccination hesitancy. The study was conducted relatively early in the pandemic outbreak during two days in June 2020.

Demographic predictors of the likelihood of being vaccinated against COVID-19 included having an income of $120,000 or higher or being a Democrat (in comparison to the reference category Republican).

The members of three political groups -- Democrat, Republican or Independent -- did not differ in their reported vaccine knowledge, however. One-fourth of those identifying with no political party reported they were not likely to get vaccinated.

The media had an effect too. Respondents relying primarily on social media for information about COVID-19 anticipated a lower likelihood of COVID-19 vaccine acceptance.

Those reporting getting their information from various other media did not show significant differences in vaccine acceptance, but viewers of Fox News did report being more hesitant than viewers of other broadcast news, the research showed.

The authors noted that it is possible that individuals gravitate toward the cable news networks that present a view on the pandemic that is aligned with their own opinions.

Media reports have regularly noted that men, adults age 65 and over, and individuals with pre-existing conditions are most vulnerable to COVID-19, and respondents from these groups said they were more likely to accept a future vaccine in this survey. A majority of the least-educated respondents did not expect to get vaccinated against COVID-19, researchers said.

The top four reasons given for vaccination hesitancy were as follows: concerns about vaccine side effects, worries about allergic responses to the vaccine, doubts about vaccine effectiveness and a preference for developing immunity through infection.

Other reasons were less frequently cited -- including being healthy, fear of needles, being immune from past infection, being young and lack of concern about developing a serious illness.

Unfortunately, the health disparities present in the spread and treatment of COVID-19 were reflected in survey participants' vaccination hesitancy estimations," researchers said in the paper. "The pandemic has especially burdened the African American, Latino, and Native American communities, who account for a disproportionate number of COVID-19 cases and deaths. Greater likelihood of COVID-19 vaccine acceptance was associated with more knowledge about vaccines, less acceptance of vaccine conspiracies, elevated COVID-19 threat appraisals, and being current with influenza immunization."

Primary findings summary

  • Male, older, white, married, and those from higher-income households more likely to vaccinate.
  • Republicans and Fox News viewers were less likely to vaccinate.
  • Being currently immunized against influenza predicted COVID-19 vaccination intent.
  • A better understanding of COVID-19 vaccination hesitancy is needed.
Source:
Journal reference:

Ruiz, J. B & Bell, R. A. (2021) Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey. Vaccine. doi.org/10.1016/j.vaccine.2021.01.010.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses